Total Payments
$28,902
2024 Payments
$3,144
Companies
56
Transactions
1,255
Medicare Patients
5,017
Medicare Billing
$759,527
Payment Breakdown by Category
Food & Beverage$25,701 (88.9%)
Gifts$2,975 (10.3%)
Education$226.31 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,701 | 1,248 | 88.9% |
| Gift | $2,975 | 1 | 10.3% |
| Education | $226.31 | 6 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $5,319 | 221 | $0 (2024) |
| GENZYME CORPORATION | $3,480 | 23 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $2,656 | 125 | $0 (2024) |
| ABBVIE INC. | $2,652 | 119 | $0 (2024) |
| PFIZER INC. | $2,253 | 132 | $0 (2024) |
| Janssen Biotech, Inc. | $1,680 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,431 | 86 | $0 (2024) |
| Lilly USA, LLC | $1,322 | 60 | $0 (2024) |
| Radius Health, Inc. | $1,225 | 55 | $0 (2024) |
| Celgene Corporation | $912.74 | 77 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,144 | 127 | ABBVIE INC. ($721.98) |
| 2023 | $3,415 | 135 | Amgen Inc. ($836.01) |
| 2022 | $3,716 | 169 | Amgen Inc. ($647.03) |
| 2021 | $2,847 | 144 | Amgen Inc. ($448.15) |
| 2020 | $1,890 | 88 | Amgen Inc. ($796.32) |
| 2019 | $3,436 | 170 | Amgen Inc. ($701.01) |
| 2018 | $3,720 | 205 | Amgen Inc. ($790.76) |
| 2017 | $6,734 | 217 | GENZYME CORPORATION ($2,975) |
All Payment Transactions
1,255 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: OSTEOPOROSIS | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $34.71 | General |
| 11/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Inflammation | ||||||
| 11/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: OSTEOPOROSIS | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,222 | 5,203 | $847,160 | $188,800 |
| 2022 | 24 | 1,251 | 4,907 | $925,698 | $203,495 |
| 2021 | 25 | 1,253 | 4,744 | $719,521 | $194,691 |
| 2020 | 22 | 1,291 | 4,506 | $451,780 | $172,542 |
Total Patients
5,017
Total Services
19,360
Medicare Billing
$759,527
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 315 | 734 | $401,750 | $72,610 | 18.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 1,920 | $57,600 | $35,514 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 350 | $157,160 | $24,932 | 15.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 18 | 91 | $27,300 | $10,899 | 39.9% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 55 | 135 | $30,375 | $10,101 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $39,600 | $9,527 | 24.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 68 | 103 | $36,050 | $4,884 | 13.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 72 | 72 | $14,400 | $3,141 | 21.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 22 | 47 | $8,930 | $2,988 | 33.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 56 | $9,600 | $2,640 | 27.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 48 | 72 | $8,957 | $2,559 | 28.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 24 | 41 | $6,098 | $1,742 | 28.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 48 | 142 | $8,520 | $1,683 | 19.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 17 | 17 | $3,400 | $1,001 | 29.4% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 14 | 22 | $3,190 | $867.52 | 27.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 111 | 933 | $9,306 | $763.59 | 8.2% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 17 | 66 | $4,950 | $759.66 | 15.3% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 12 | 19 | $2,850 | $646.76 | 22.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 72 | $1,080 | $604.80 | 56.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 14 | 70 | $7,000 | $452.55 | 6.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 27 | $3,375 | $303.84 | 9.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 13 | 17 | $204.00 | $98.41 | 48.2% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 19 | 93 | $4,185 | $47.63 | 1.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 32 | $1,280 | $32.74 | 2.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 307 | 836 | $455,000 | $86,471 | 19.0% |
About Dr. David Hallegua, M.D
Dr. David Hallegua, M.D is a Rheumatology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063416964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hallegua, M.D has received a total of $28,902 in payments from pharmaceutical and medical device companies, with $3,144 received in 2024. These payments were reported across 1,255 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($25,701).
As a Medicare-enrolled provider, Hallegua has provided services to 5,017 Medicare beneficiaries, totaling 19,360 services with total Medicare billing of $759,527. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Beverly Hills, CA
- Active Since 06/08/2005
- Last Updated 03/17/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1063416964
Products in Payments
- Enbrel (Biological) $3,057
- SYNVISC-ONE (Device) $2,987
- XELJANZ (Drug) $1,869
- COSENTYX (Biological) $1,674
- BENLYSTA (Biological) $1,431
- RINVOQ (Biological) $1,245
- TALTZ (Drug) $920.22
- Humira (Biological) $849.31
- EVENITY (Biological) $765.29
- COSENTYX (Drug) $747.42
- SIMPONI ARIA (Biological) $742.99
- KRYSTEXXA (Biological) $673.29
- Tymlos (Biological) $672.28
- ACTHAR (Biological) $615.20
- SAPHNELO (Biological) $517.86
- Otezla (Drug) $441.64
- FORTEO (Drug) $402.01
- REMICADE (Biological) $399.33
- Rituxan (Biological) $369.34
- AVSOLA (Biological) $356.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Beverly Hills
Dr. Daniel Wallace, M.d, M.D
Rheumatology — Payments: $325,831
Rheumatology $325,831
Daphne Scaramangas-Plumley, Md, MD
Rheumatology — Payments: $73,217
Rheumatology $73,217
R Swamy Venuturupalli, M.d, M.D
Rheumatology — Payments: $33,943
Rheumatology $33,943
Dr. Dahlia Carr, Md, MD
Rheumatology — Payments: $16,793
Rheumatology $16,793
Dr. Renee Rinaldi, Md, MD
Rheumatology — Payments: $8,689
Rheumatology $8,689
Dr. Seymour Levine, Md, MD
Rheumatology — Payments: $4,741
Rheumatology $4,741